Search research articles
Contact Us
Filters
Showing results (211-220 of 245) with videos related to
Page
of 25
Sort By:
JACC. Heart Failure
|
August 12, 2019
The Risk for Sudden Cardiac Death Among Patients Living With Heart Failure and Human Immunodeficiency Virus
Raza M Alvi, Anne M Neilan, Noor Tariq, et al.
Leukemia & Lymphoma
|
February 15, 2014
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia
Stephen P Mulligan, Karin Karlsson, Mats Strömberg, et al.
Leukemia & Lymphoma
|
August 13, 2021
Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Jennifer Woyach, Alessandra Tedeschi, Talha Munir, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 13, 2025
FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer
Junyao Zhu, Xinyi Dai, Santanu Ghosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2019
Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure
Raza M Alvi, Markella V Zanni, Anne M Neilan, et al.
Cytokine
|
January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers
Sarah C Sasson, Sandy Smith, Nabila Seddiki, et al.
Blood Cancer Journal
|
February 4, 2017
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
M Montillo, S O'Brien, A Tedeschi, et al.
Leukemia Research
|
September 10, 2020
Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia
Isabelle G Solman, Lisa K Blum, Hana Y Hoh, et al.
Blood Advances
|
January 17, 2024
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon
Thomas E Lew, Rory Bennett, Victor S Lin, et al.
British Journal of Haematology
|
December 28, 2021
COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity
Yandong Shen, Jane A Freeman, Juliette Holland, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 245) with videos related to
Sort By:
Page
of 25
JACC. Heart Failure
|
August 12, 2019
The Risk for Sudden Cardiac Death Among Patients Living With Heart Failure and Human Immunodeficiency Virus
Raza M Alvi, Anne M Neilan, Noor Tariq, et al.
Leukemia & Lymphoma
|
February 15, 2014
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia
Stephen P Mulligan, Karin Karlsson, Mats Strömberg, et al.
Leukemia & Lymphoma
|
August 13, 2021
Using ibrutinib in earlier lines of treatment results in better outcomes for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
Jennifer Woyach, Alessandra Tedeschi, Talha Munir, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 13, 2025
FGD3 mediates lytic cell death, enhancing efficacy and immunogenicity of chemotherapy agents in breast cancer
Junyao Zhu, Xinyi Dai, Santanu Ghosh, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 20, 2019
Amino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart Failure
Raza M Alvi, Markella V Zanni, Anne M Neilan, et al.
Cytokine
|
January 12, 2010
IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers
Sarah C Sasson, Sandy Smith, Nabila Seddiki, et al.
Blood Cancer Journal
|
February 4, 2017
Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
M Montillo, S O'Brien, A Tedeschi, et al.
Leukemia Research
|
September 10, 2020
Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia
Isabelle G Solman, Lisa K Blum, Hana Y Hoh, et al.
Blood Advances
|
January 17, 2024
Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon
Thomas E Lew, Rory Bennett, Victor S Lin, et al.
British Journal of Haematology
|
December 28, 2021
COVID-19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B-lymphocytosis; humoural and cellular immunity
Yandong Shen, Jane A Freeman, Juliette Holland, et al.
Page
of 25